Neuropathobiology of Senile Dementia and Mechanism of Action of Nootropic Drugs
- 1 April 1994
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 4 (4) , 285-303
- https://doi.org/10.2165/00002512-199404040-00002
Abstract
Recent advances in neuroscience and molecular neurochemistry have substantially increased the knowledge of the neuropathobiology of senile dementia and Alzheimer’s disease. On the basis of various...Keywords
This publication has 98 references indexed in Scilit:
- Somatostatin in Alzheimer's disease and depressionLife Sciences, 1992
- Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.Stroke, 1991
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- On the role of intracellular physicochemistry in quantitative gene expression during aging and the effect of centrophenoxine. A reviewArchives of Gerontology and Geriatrics, 1989
- Effects of idebenone on lipid peroxidation and hemolysis in erythrocytes of stroke-prone spontaneously hypertensive ratsArchives of Gerontology and Geriatrics, 1989
- Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brainsNeuroscience Letters, 1986
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Effects of prolonged co-dergocrine mesylate (Hydergine®) treatment on local cerebral glucose uptake in aged Fischer 344 ratsArchives of Gerontology and Geriatrics, 1986
- Reduced Numbers of Somatostatin Receptors in the Cerebral Cortex in Alzheimer's DiseaseScience, 1985
- A membrane hypothesis of agingJournal of Theoretical Biology, 1978